Shefali Agarwal

Track

Insider profile

Currently holds a position at Fate Therapeutics Inc

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return -34% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Fate Therapeutics Inc July 15, 2019 -
Shefali Agarwal's trades of Kanpur Plastipack Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
205.79
Quantity 9,157
Value ₹1,501,381
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
1.50
Quantity 1,058 -0.7%
Value US$1,587
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
1.37
Quantity 2,639 -1.6%
Value US$3,615
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
2.02
Quantity 2,922 -1.8%
Value US$5,902
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
2.93
Quantity 1,780 -1.1%
Value US$5,215
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
11.21
Quantity 969 -0.9%
Value US$10,862
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
11.41
Quantity 2,872 -3.7%
Value US$32,770
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
13.54
Quantity 2,522 -3.2%
Value US$34,148
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
15.28
Quantity 1,243 -1.7%
Value US$18,993
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
20.44
Quantity 2,630 -4.3%
Value US$53,757
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
24.64
Quantity 1,843 -2.9%
Value US$45,412
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
11.97
Quantity 1,195 -3.2%
Value US$14,304
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-11 2025-12-09
B Purchase
9,157
205.79
₹1,501,381 		9,157 205.79 ₹1,501,381
2022-06-08 2022-06-07
S Sale
2,983 +26.4%
174.65
US$3,423,344 		2,983 +26.4% 174.65 US$3,423,344
2022-06-06 2022-06-03
S Sale
66,946 +14.5%
352.67
US$3,553,916 		66,946 +14.5% 352.67 US$3,553,916
2022-02-09 2022-02-07
US Epizyme Inc (EPZM)
PlS Planned sale
1,058 -0.7%
1.50
US$1,587 		1,058 -0.7% 1.50 US$1,587
2022-02-04 2022-02-02
US Epizyme Inc (EPZM)
PlS Planned sale
2,639 -1.6%
1.37
US$3,615 		2,639 -1.6% 1.37 US$3,615
2022-01-28 2022-01-26
US Epizyme Inc (EPZM)
PlS Planned sale
2,922 -1.8%
2.02
US$5,902 		2,922 -1.8% 2.02 US$5,902
2021-12-07 2021-12-06
US Epizyme Inc (EPZM)
PlS Planned sale
1,780 -1.1%
2.93
US$5,215 		1,780 -1.1% 2.93 US$5,215
2021-02-05 2021-02-04
US Epizyme Inc (EPZM)
PlS Planned sale
969 -0.9%
11.21
US$10,862 		969 -0.9% 11.21 US$10,862
2021-01-27 2021-01-25
US Epizyme Inc (EPZM)
PlS Planned sale
2,872 -3.7%
11.41
US$32,770 		2,872 -3.7% 11.41 US$32,770
2020-12-07 2020-12-03
US Epizyme Inc (EPZM)
PlS Planned sale
2,522 -3.2%
13.54
US$34,148 		2,522 -3.2% 13.54 US$34,148
2020-03-26 2020-03-25
US Epizyme Inc (EPZM)
PlS Planned sale
1,243 -1.7%
15.28
US$18,993 		1,243 -1.7% 15.28 US$18,993
2020-01-27 2020-01-27
US Epizyme Inc (EPZM)
PlS Planned sale
2,630 -4.3%
20.44
US$53,757 		2,630 -4.3% 20.44 US$53,757
2020-01-27 2020-01-24
US Epizyme Inc (EPZM)
PlS Planned sale
1,843 -2.9%
24.64
US$45,412 		1,843 -2.9% 24.64 US$45,412
2019-06-17 2019-06-14
US Epizyme Inc (EPZM)
PlS Planned sale
1,195 -3.2%
11.97
US$14,304 		1,195 -3.2% 11.97 US$14,304